Fungal infections: a survey of laboratory services for diagnosis and treatment.
A questionnaire on the services provided and the methods used for the diagnosis of fungal infections and for the support of antifungal chemotherapy was sent to members of the British Society for Medical Mycology (BSMM) and the British Society for Antimicrobial Chemotherapy (BSAC). Ninety-five responses from general microbiology laboratories in the United Kingdom were analysed, and we compared services provided by laboratories that serve a transplant unit with those offered by other laboratories. We estimate that about 150 cases of cryptococcosis, 500 to 600 of candidaemia, and 300 to 400 of invasive aspergillosis are identified by laboratories in the United Kingdom (UK) each year. The clinical laboratories are aware of the importance of fungal infection, but rely heavily on reference services. In some laboratories, however, the degree of investigation of specimens and the procedures in use are inadequate for diagnosing systemic mycoses and determining the susceptibility of isolates to antifungal agents. The balance between reference and local services requires attention and external quality assurance needs to be applied effectively. In addition, effective methods for the diagnosis of systemic mycoses, and reliable and practicable methods for determining the susceptibility of isolates to antifungal agents, are needed urgently.
Barnes
R A
RA
Department of Medical Microbiology, University of Wales College of Medicine, Cardiff.
Denning
D W
DW
Evans
E G
EG
Hay
R J
RJ
Kibbler
C C
CC
Prentice
A G
AG
Richardson
M D
MD
Roberts
M M
MM
Rogers
T R
TR
Speller
D C
DC
Warnock
D W
DW
Warren
R E
RE
D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008826:Microbial Sensitivity Tests; D016533:Mycological Typing Techniques; D009181:Mycoses / Q000175:diagnosis* / Q000188:drug therapy; D011237:Predictive Value of Tests; D006113:United Kingdom
D000935:Antifungal Agents